Invasive Candidiasis in Adult Patients with COVID-19: Results of a Multicenter Study in St. Petersburg, Russia.
COVID-19
Candida
SARS-CoV-2
acute respiratory distress syndrome
candidiasis
fungal
mycoses
yeast
Journal
Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827
Informations de publication
Date de publication:
14 Sep 2023
14 Sep 2023
Historique:
received:
08
08
2023
revised:
10
09
2023
accepted:
12
09
2023
medline:
27
9
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
We studied the risk factors, etiology, clinical manifestations, and treatment outcomes of COVID-19-associated invasive candidiasis (COVID-IC) in adult patients admitted to six medical facilities in St. Petersburg. (November 2020-December 2022). In this retrospective study, we included 72 patients with COVID-IC with a median age of 61 years (range 29-96), 51% of whom were women. The predisposing factors for COVID-IC were a central venous catheter (CVC) for more than 10 days (the odds ratio (OR) = 70 [15-309]), abdominal surgical treatment performed in the previous 2 weeks (OR = 8.8 [1.9-40.3]), bacteremia (OR = 10.6 [4.8-23.3]), pulmonary ventilation (OR = 12.9 [5.9-28.4]), and hemodialysis (OR = 11.5 [2.5-50.8]). The signs and symptoms of COVID-IC were non-specific: fever (59%), renal failure (33%), liver failure (23%), and cardiovascular failure (10%).
Identifiants
pubmed: 37755035
pii: jof9090927
doi: 10.3390/jof9090927
pmc: PMC10532874
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Crit Care. 2008 Mar;23(1):11-7
pubmed: 18359416
Clin Infect Dis. 2022 Mar 9;74(5):802-811
pubmed: 34145450
Autoimmun Rev. 2020 Jul;19(7):102564
pubmed: 32376396
Crit Care. 2020 May 28;24(1):269
pubmed: 32466803
Emerg Infect Dis. 2020 Nov;26(11):2694-2696
pubmed: 32852265
FEMS Microbiol Lett. 2016 Sep;363(18):
pubmed: 27573235
Antimicrob Agents Chemother. 2012 May;56(5):2518-23
pubmed: 22314534
Clin Microbiol Infect. 2021 Jan;27(1):83-88
pubmed: 32745596
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Clin Infect Dis. 2010 Sep 1;51(5):e38-45
pubmed: 20636126
Front Cell Infect Microbiol. 2020 May 21;10:206
pubmed: 32509592
J Fungi (Basel). 2021 Dec 10;7(12):
pubmed: 34947041
Chest. 2006 Jan;129(1):110-7
pubmed: 16424420
Lancet Infect Dis. 2021 Jun;21(6):e149-e162
pubmed: 33333012
Clin Infect Dis. 2020 Dec 17;71(10):2736-2743
pubmed: 32361747
J Glob Antimicrob Resist. 2020 Sep;22:175-176
pubmed: 32535077
Mycoses. 2021 Sep;64(9):1083-1091
pubmed: 34085319
J Fungi (Basel). 2022 Mar 16;8(3):
pubmed: 35330307
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376
pubmed: 31802125
Future Microbiol. 2020 Sep;15:1405-1413
pubmed: 33085538
Front Med (Lausanne). 2021 Feb 04;7:598037
pubmed: 33614672
J Fungi (Basel). 2020 Oct 08;6(4):
pubmed: 33050019
Curr Microbiol. 2022 Mar 14;79(5):127
pubmed: 35287179
Intensive Care Med. 2019 Jun;45(6):789-805
pubmed: 30911804